Cerenis Therapeutics (France)

Efficacy and Safety of Rivaroxaban Compared With Warfarin Among Elderly Patients With Nonvalvular Atrial Fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)

Jonathan L. Halperin, Graeme J. Hankey, Daniel Wojdyla et al. · Circulation · 2014 · 427 citations · Full text

A combinatorial approach to create artificial homing endonucleases cleaving chosen sequences

Julianne Smith, Sylvestre Grizot, Sylvain Arnould et al. · Nucleic Acids Research · 2006 · 314 citations · Full text

Engineering, Reverse Genetics, Genetics +23

Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial

Jean‐Claude Tardif, Christie M. Ballantyne, Philip J. Barter et al. · European Heart Journal · 2014 · 248 citations · Full text

Effect of Serial Infusions of CER-001, a Pre-β High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER-001 Atherosclerosis Regression Acute Coronary Syndrome Trial

Stephen J. Nicholls, Jordan Andrews, John J.P. Kastelein et al. · JAMA Cardiology · 2018 · 178 citations · Full text

CER-001, a HDL-mimetic, stimulates the reverse lipid transport and atherosclerosis regression in high cholesterol diet-fed LDL-receptor deficient mice

Claudine Tardy, Marine Goffinet, Nadia Boubekeur et al. · Atherosclerosis · 2013 · 110 citations · Full text